Relay Therapeutics Inc. (RLAY): Price and Financial Metrics Recent IPO


Relay Therapeutics Inc. (RLAY) Recent IPO

Today's Latest Price: $54.00 USD

0.27 (0.50%)

Updated Nov 24 4:00pm

Add RLAY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

RLAY Stock Price Chart Interactive Chart >

Price chart for RLAY

RLAY Price/Volume Stats

Current price $54.00 52-week high $57.59
Prev. close $53.73 52-week low $32.56
Day low $53.06 Volume 265,400
Day high $57.59 Avg. volume 367,238
50-day MA $42.64 Dividend yield N/A
200-day MA $0.00 Market Cap 4.86B

Relay Therapeutics Inc. (RLAY) Company Bio


Relay Therapeutics, Inc. is a clinical-stage precision medicines company. It focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.


RLAY Latest News Stream


Event/Time News Detail
Loading, please wait...

RLAY Latest Social Stream


Loading social stream, please wait...

View Full RLAY Social Stream

Latest RLAY News From Around the Web

Below are the latest news stories about Relay Therapeutics Inc that investors may wish to consider to help them evaluate RLAY as an investment opportunity.

These Are The Four Biotech Stocks Recently Pitched At The Ira Sohn Conference

Four not-widely-followed biotech stocks were pitched at the recent Ira Sohn conference. Below is the full audio of the pitches, and a list of the publicly-traded landscape for each....

SA News Team on Seeking Alpha | October 3, 2020

Relay Therapeutics: Heavily Backed Biotech Brains Trust Looks A Long-Term Buy

Investment Thesis Relay Therapeutics share price performance since IPO (Source: TradingView) Investors looking to place a bet on the next big biotech trend may want to take a close look at Relay Therapeutics (RLAY), a novel drug discovery startup with a strong management team, access to one of the world's...

Edmund Ingham on Seeking Alpha | September 7, 2020

Read More 'RLAY' Stories Here

RLAY Price Returns

1-mo 43.77%
3-mo 48.64%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.786 seconds.